Emergency Medicine · Toxicology
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Suspect it with GI distress (nausea/vomiting) plus a coarse resting tremor, ataxia, and confusion in a patient on lithium.
Often precipitated by decreased renal clearance from NSAIDs, thiazides, or ACE inhibitors, or by volume depletion.
Confirmed by a serum lithium > 1.5 mEq/L, with an ECG classically showing T-wave flattening or inversion.
First-line therapy is aggressive volume resuscitation with IV normal saline to restore GFR and renal lithium clearance.
Hemodialysis is definitive and indicated for levels > 4.0 mEq/L, or > 2.5 mEq/L with severe symptoms, renal failure, or instability.
Do not use activated charcoal, as it does not bind lithium ions.
A fine tremor is a normal therapeutic effect, whereas a coarse tremor is a red flag for toxicity.
Vignette unlocked
A 45-year-old woman with bipolar disorder maintained on lithium presents with two days of nausea, vomiting, and unsteady gait. She recently started hydrochlorothiazide for hypertension. On exam she is confused with a coarse tremor of the hands, ataxia, and hyperreflexia. Serum lithium is 2.8 mEq/L and creatinine is mildly elevated; ECG shows T-wave flattening.
Which of the following is the most appropriate initial step in management?
Aggressive volume resuscitation with IV normal saline.
The thiazide reduced renal lithium clearance, producing chronic toxicity with the classic coarse tremor, ataxia, and confusion. IV normal saline restores GFR and enhances renal lithium excretion as first-line therapy; hemodialysis would be reserved for levels > 4.0 mEq/L or severe neurologic compromise, and charcoal is ineffective for ions.
Full handout
High yield triage
Etiology / Epidemiology
Caused by intentional overdose or decreased renal clearance due to interacting drugs (NSAIDs, Thiazides, ACE inhibitors).
Clinical Manifestations
Presents with GI distress (nausea/vomiting) and neurologic signs like a coarse tremor, ataxia, and confusion.
Diagnosis
Confirmed by a serum lithium > 1.5 mEq/L and ECG showing T-wave flattening or inversion.
Treatment
Initiate IV normal saline for aggressive hydration; use Hemodialysis if levels are > 4.0 mEq/L or severe symptoms are present.
Prognosis
Generally reversible, but severe cases risk permanent neurologic damage if clearance is not rapidly restored.
Full handout
Epidemiology & Etiology
Lithium has a narrow therapeutic index (0.6-1.2 mEq/L), making toxicity common even at standard doses. Toxicity is classically precipitated by decreased renal clearance due to dehydration, hyponatremia, or advanced age. The quintessential board-tested drug interactions that precipitate toxicity are Thiazide diuretics, NSAIDs, and ACE inhibitors/ARBs.
Pertinent Anatomy
Lithium is a small, univalent cation that is freely filtered at the glomerulus. It is reabsorbed primarily alongside sodium in the proximal convoluted tubule (PCT). Because the nephron cannot distinguish lithium from sodium, any state causing proximal sodium retention (e.g., volume depletion) will paradoxically increase lithium reabsorption, leading to toxic accumulation.
Pathophysiology
Lithium substitutes for cellular cations (Na+, K+) and disrupts transmembrane ion pumps and intracellular secondary messengers. In the renal collecting duct, it blocks ADH signaling, causing nephrogenic diabetes insipidus, which drives volume depletion and further secondary decreased lithium clearance. In the CNS, this toxic accumulation deranges neurotransmitter release, leading to neuronal excitotoxicity.
Clinical Manifestations
Acute toxicity primarily presents with prominent gastrointestinal symptoms (nausea, vomiting, diarrhea) followed by delayed neurologic signs. Chronic toxicity presents insidiously with neurologic findings: hyperreflexia, ataxia, confusion, and the classic coarse resting tremor. Severe toxicity progresses to seizures, coma, or fatal ventricular arrhythmias. Note that a fine tremor is a normal therapeutic side effect, whereas a coarse tremor is a red flag for toxicity.
Diagnosis
The gold standard for diagnosis is a serum lithium level > 1.5 mEq/L, though clinical severity dictates management more than the absolute number. A basic metabolic panel is mandatory to assess for acute kidney injury and underlying electrolyte derangements. An ECG must be obtained and classically reveals T-wave flattening or inversion, with severe cases showing bradycardia or AV block.
Treatment
The first-line therapy is aggressive volume resuscitation with IV normal saline to restore GFR and maximize renal lithium clearance. Hemodialysis is the definitive treatment and is indicated for levels > 4.0 mEq/L, or > 2.5 mEq/L if accompanied by severe neurologic symptoms, renal failure, or hemodynamic instability. Do not use activated charcoal for GI decontamination, as it does not bind heavy metals or ions.
Prognosis
Most patients recover fully with prompt IV hydration and discontinuation of the offending agent. However, delayed treatment or profound overdose can lead to the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT), characterized by permanent cerebellar ataxia, dysarthria, and cognitive impairment. Frequent monitoring of renal function and thyroid function is required for all patients on chronic therapy.
Differential Diagnosis
1. Serotonin Syndrome: Presents with altered mental status and GI symptoms but features autonomic instability and classic hyperreflexia and myoclonus.
2. Neuroleptic Malignant Syndrome: Features severe hyperthermia and lead-pipe rigidity following administration of dopamine antagonists.
3. Alcohol Withdrawal: Presents with tremor, agitation, and autonomic hyperactivity with a history of abrupt cessation.
4. Hypoglycemia: Causes confusion, tremor, and diaphoresis but is diagnosed by a capillary blood glucose < 70 mg/dL.